National Health Service, United Kingdom
60
2
2
37
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.0%
3 terminated/withdrawn out of 60 trials
92.5%
+6.0% vs industry average
5%
3 trials in Phase 3/4
14%
5 of 37 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (60)
Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit
Role: collaborator
Adiposity and Iron Requirements in Pregnancy
Role: collaborator
Use of MonitorMe in COPD
Role: collaborator
Digitally-Enabled Weight Management Program on T2DM
Role: collaborator
LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
Role: collaborator
High Energy High Protein Peptide Feed Study
Role: collaborator
Incentives in Diabetic Eye Assessment by Screening
Role: collaborator
Trial Feasibility of Home Delivery of Colon Capsule Endoscopy Service With the Help of 5 G Technology
Role: lead
Guided Self-help Following Sexual Assault - SCED
Role: collaborator
A Prospective Randomized Controlled Trial to Evaluate the Effectiveness of the Two Different Appliances in the Treatment of Class II Division 1 Malocclusion
Role: collaborator
The Experience of Screening for SCID
Role: collaborator
Surgeon Ergonomics in Robotic-assisted Laparoscopic Vs Standard Laparoscopic Surgery
Role: collaborator
Narrative Exposure Therapy to Reduce Symptoms of Traumatic Stress in Cancer Survivors
Role: collaborator
The Effect of Varying Brightness on Palpebral Aperture
Role: collaborator
Impact of an Enhanced Sterile Protocol on Root Canal Treatment Outcome
Role: collaborator
A Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD)
Role: collaborator
Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery
Role: collaborator
Hair Cycle Modulation To Promote Human Wound Healing
Role: collaborator
Rifaximin in Fatty Liver Disease
Role: collaborator
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Role: collaborator